|
1
|
Li H, Peng Y, Niu H, Wu B, Zhang Y, Zhang
Y, Bai X and He P: SPAG9 is overexpressed in human prostate cancer
and promotes cancer cell proliferation. Tumour Biol. 35:6949–6954.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kanojia D, Garg M, Gupta S, Gupta A and
Suri A: Sperm-associated antigen 9 is a novel biomarker for
colorectal cancer and is involved in tumor growth and
tumorigenicity. Am J Pathol. 178:1009–1020. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Peng JR, Chen HS, Mou DC, Cao J, Cong X,
Qin LL, Wei L, Leng XS, Wang Y and Chen WF: Expression of
cancer/testis (CT) antigens in Chinese hepatocellular carcinoma and
its correlation with clinical parameters. Cancer Lett. 219:223–232.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yang P, Huo Z, Liao H and Zhou Q:
Cancer/testis antigens trigger epithelial-mesenchymal transition
and genesis of cancer stem-like cells. Curr Pharm Des.
21:1292–1300. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Garg M, Chaurasiya D, Rana R, Jagadish N,
Kanojia D, Dudha N, Kamran N, Salhan S, Bhatnagar A, Suri S, et al:
Sperm-associated antigen 9, a novel cancer testis antigen, is a
potential target for immunotherapy in epithelial ovarian cancer.
Clin Cancer Res. 13:1421–1428. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Garg M, Kanojia D, Khosla A, Dudha N, Sati
S, Chaurasiya D, Jagadish N, Seth A, Kumar R, Gupta S, et al:
Sperm-associated antigen 9 is associated with tumor growth,
migration, and invasion in renal cell carcinoma. Cancer Res.
68:8240–8248. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Garg M, Kanojia D, Salhan S, Suri S, Gupta
A, Lohiya NK and Suri A: Sperm-associated antigen 9 is a biomarker
for early cervical carcinoma. Cancer. 115:2671–2683. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Garg M, Kanojia D, Suri S, Gupta S, Gupta
A and Suri A: Sperm-associated antigen 9: A novel diagnostic marker
for thyroid cancer. J Clin Endocrinol Metab. 94:4613–4618. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kanojia D, Garg M, Gupta S, Gupta A and
Suri A: Sperm-associated antigen 9, a novel biomarker for early
detection of breast cancer. Cancer Epidemiol Biomarkers Prev.
18:630–639. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yu P, Yan L, Zhang H, Lin X and Zhao X:
Expression and clinical significance of sperm-associated antigen 9
in patients with endometrial carcinoma. Int J Gynecol Cancer.
22:87–93. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Garg M, Kanojia D, Suri S and Suri A:
Small interfering RNA-mediated down-regulation of SPAG9 inhibits
cervical tumor growth. Cancer. 115:5688–5699. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sinha A, Agarwal S, Parashar D, Verma A,
Saini S, Jagadish N, Ansari AS, Lohiya NK and Suri A: Down
regulation of SPAG9 reduces growth and invasive potential of
triple-negative breast cancer cells: Possible implications in
targeted therapy. J Exp Clin Cancer Res. 32:692013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yi F, Ni W, Liu W, Pan X, Han X, Yang L,
Kong X, Ma R and Chang R: SPAG9 is overexpressed in human
astrocytoma and promotes cell proliferation and invasion. Tumour
Biol. 34:2849–2855. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang Y, Dong Q, Miao Y, Fu L, Lin X and
Wang E: Clinical significance and biological roles of SPAG9
overexpression in non-small cell lung cancer. Lung Cancer.
81:266–272. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kanojia D, Garg M, Saini S, Agarwal S,
Parashar D, Jagadish N, Seth A, Bhatnagar A, Gupta A, Kumar R, et
al: Sperm associated antigen 9 plays an important role in bladder
transitional cell carcinoma. PLoS One. 8:e813482013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Agarwal S, Parashar D, Gupta N, Jagadish
N, Thakar A, Suri V, Kumar R, Gupta A, Ansari AS, Lohiya NK and
Suri A: Sperm associated antigen 9 (SPAG9) expression and humoral
response in benign and malignant salivary gland tumors.
Oncoimmunology. 3:e9743822014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nordenstedt H, White DL and El-Serag HB:
The changing pattern of epidemiology in hepatocellular carcinoma.
Dig Liver Dis. 42 Suppl 3:S206–S214. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li P, Cao Y, Li Y, Zhou L, Liu X and Geng
M: Expression of Wnt-5a and β-catenin in primary hepatocellular
carcinoma. Int J Clin Exp Pathol. 7:3190–3195. 2014.PubMed/NCBI
|
|
20
|
Gauglhofer C, Paur J, Schrottmaier WC,
Wingelhofer B, Huber D, Naegelen I, Pirker C, Mohr T, Heinzle C,
Holzmann K, et al: Fibroblast growth factor receptor 4: A putative
key driver for the aggressive phenotype of hepatocellular
carcinoma. Carcinogenesis. 35:2331–2338. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chu R, Mo G, Duan Z, Huang M, Chang J, Li
X and Liu P: miRNAs affect the development of hepatocellular
carcinoma via dysregulation of their biogenesis and expression.
Cell Commun Signal. 12:452014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xu WH, Zhang JB, Dang Z, Li X, Zhou T, Liu
J, Wang DS, Song WJ and Dou KF: Long non-coding RNA URHC regulates
cell proliferation and apoptosis via ZAK through the ERK/MAPK
signaling pathway in hepatocellular carcinoma. Int J Biol Sci.
10:664–676. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kanojia D, Garg M, Gupta S, Gupta A and
Suri A: Sperm-associated antigen 9, a novel biomarker for early
detection of breast cancer. Cancer Epidemiol Biomarkers Prev.
18:630–639. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang H, Xiong FX, Lin M, Yang Y, Nie X and
Zhou RL: LAPTM4B-35 overexpression is a risk factor for tumor
recurrence and poor prognosis in hepatocellular carcinoma. J Cancer
Res Clin Oncol. 136:275–281. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhao ZK, Dong P, Gu J, Chen L, Zhuang M,
Lu WJ, Wang DR and Liu YB: Overexpression of LSD1 in hepatocellular
carcinoma: A latent target for the diagnosis and therapy of
hepatoma. Tumour Biol. 34:173–180. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Marquardt JU, Galle PR and Teufel A:
Molecular diagnosis and therapy of hepatocellular carcinoma (HCC):
An emerging field for advanced technologies. J Hepatol. 56:267–275.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xie C, Fu L, Liu N and Li Q:
Overexpression of SPAG9 correlates with poor prognosis and tumor
progression in hepatocellular carcinoma. Tumour Biol. 35:7685–7691.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ha JH, Yan M, Gomathinayagam R, Jayaraman
M, Husain S, Liu J, Mukherjee P, Reddy EP, Song YS and Dhanasekaran
DN: Aberrant expression of JNK-associated leucine-zipper protein,
JLP, promotes accelerated growth of ovarian cancer. Oncotarget.
7:72845–72859. 2016.PubMed/NCBI
|
|
29
|
Jagadish N, Rana R, Mishra D, Kumar M and
Suri A: Sperm associated antigen 9 (SPAG9): A new member of c-Jun
NH2 -terminal kinase (JNK) interacting protein exclusively
expressed in testis. Keio J Med. 54:66–71. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Edmondson HA and Steiner PE: Primary
carcinoma of the liver: A study of 100 cases among 48,900
necropsies. Cancer. 7:462–503. 1954. View Article : Google Scholar : PubMed/NCBI
|
